Biopharmaceutical benchmarks 2022

Nat Biotechnol. 2022 Dec;40(12):1722-1760. doi: 10.1038/s41587-022-01582-x.

Abstract

Monoclonal antibodies as a group continue to lead biopharmaceuticals in numbers of approvals and sales, although COVID-19 vaccines shot to the top of the list of highest-grossing individual products.

MeSH terms

  • Benchmarking
  • Biological Products*
  • Drug Approval
  • Drug Industry

Substances

  • Biological Products